Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOSE: 1,8-cineole vs mupirocin for MRSA nasal carriage
2025-521569-29-00Phase 3Withdrawn
- Sponsor
- Wroclaw Medical University
- Start
- Apr 2026
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Staphylococcus aureus infection and chronic rhinitis comparing 1,8-cineole monotherapy, Mupirocin monotherapy and 1,8-cineole + mupirocin combination (3 arms). Planned start Apr 2026; status: withdrawn.
02
Drugs
eucalyptolmupirocin
03
Conditions
Staphylococcus aureus infectionchronic rhinitis
Beyond the preview
Go deeper on 2025-521569-29-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521569-29-00.